The commensal consortium of the gut microbiome is associated with favorable responses to anti-programmed death protein 1 (PD-1) therapy in thoracic neoplasms

OBJECTIVE: Immune checkpoint inhibitors have revolutionized cancer therapy for multiple types of solid tumors, but as expected, a large percentage of patients do not show durable responses. Biomarkers that can predict clinical responses to immunotherapies at diagnosis are therefore urgently needed....

Descripción completa

Detalles Bibliográficos
Autores principales: Yin, Huihui, Yang, Lu, Peng, Gongxin, Yang, Ke, Mi, Yuling, Hu, Xingsheng, Hao, Xuezhi, Jiao, Yuchen, Wang, Xiaobing, Wang, Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Compuscript 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8610161/
https://www.ncbi.nlm.nih.gov/pubmed/33960176
http://dx.doi.org/10.20892/j.issn.2095-3941.2020.0450

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8610161/
https://www.ncbi.nlm.nih.gov/pubmed/33960176
http://dx.doi.org/10.20892/j.issn.2095-3941.2020.0450

Ejemplares similares